TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,113 | -34.8% | 550 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $46,189 | +10.9% | 550 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $41,652 | +22.7% | 550 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $33,946 | +47.6% | 550 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $23,000 | +35.3% | 550 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | +30.8% | 550 | +10.0% | 0.00% | – |
| Q1 2022 | $13,000 | +30.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -41.2% | 500 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $17,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $17,000 | -19.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | +110.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | +42.9% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -22.2% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 923,221 | $30,632,000 | 5.64% |
| Sandhill Capital Partners LLC | 1,429,432 | $47,429,000 | 3.70% |
| Bullseye Asset Management LLC | 117,471 | $3,898,000 | 1.31% |
| Taylor Wealth Management Partners | 72,685 | $2,412,000 | 0.85% |
| Signature Wealth Management Partners, LLC | 14,000 | $465,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 369,259 | $12,252,000 | 0.40% |
| Triumph Capital Management | 20,051 | $622,000 | 0.36% |
| EMERALD ADVISERS, LLC | 300,464 | $9,969,000 | 0.36% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,347 | $2,533,000 | 0.30% |
| Bellevue Group AG | 729,989 | $24,221,000 | 0.24% |